Pfizer’s Inhibitor Drug Able to Reduce Neurodegeneration in Parkinson’s Disease Animal Models
Researchers at the University of Alabama at Birmingham (UAB) and Pfizer Inc. recently reported encouraging findings on a new inhibitor drug that can reduce neurodegeneration in animal models of Parkinson’s disease. The study was published in The Journal of Biological Chemistry and is entitled “…